We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+9.84%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$3.67T
AUM Growth
+$273B
(+8%)
Cap. Flow
+$30.8B
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
4,644
New
41
Increased
3,401
Reduced
945
Closed
112
Avg Time Held
6.4
years
Top 10 Avg Time Held
4.6
years
Top 20 Avg Time Held
4.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$2.67B |
| 2 |
Ferguson
FERG
|
+$2.17B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
Microsoft
MSFT
|
+$2.02B |
| 5 |
Amazon
AMZN
|
+$1.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$3.16B |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$2.44B |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$1.51B |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$1.29B |
| 5 |
Y
Alleghany Corp
Y
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Healthcare | 14.85% |
| 3 | Financials | 14.17% |
| 4 | Industrials | 9.67% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AVCT
4101
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
| $495K | ﹤0.01% |
430,573
+199,598
| +86% | +$251K |
2020 Q3
9 quarters
|
|
4102
Hyperfine
HYPR
$82.1M
| $493K | ﹤0.01% |
587,495
+997
| +0.2% | +$903 |
2022 Q1
3 quarters
|
|
4103
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $492K | ﹤0.01% |
22,792
+9
| +0% | +$245 |
2021 Q2
6 quarters
|
|
|
EMCF
4104
DELISTED
Emclaire Financial Corp
EMCF
| $490K | ﹤0.01% |
15,500
+23
| +0.1% | +$732 |
2018 Q4
16 quarters
|
|
4105
Neonode
NEON
$13.4M
| $489K | ﹤0.01% |
88,925
+3,283
| +4% | +$14.3K |
2013 Q2
38 quarters
|
|
4106
VistaGen Therapeutics
VTGN
$9.1M
| $488K | ﹤0.01% |
157,801
-53
| -0% | -$199 |
2018 Q1
19 quarters
|
|
4107
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $487K | ﹤0.01% |
33,833
+162
| +0.5% | +$5.42K |
2021 Q1
7 quarters
|
|
4108
SUNation Energy
SUNE
$13.9M
| $485K | ﹤0.01% |
+1
| New | +$459K |
2022 Q4
0 quarters
|
|
4109
Sprott
SII
$2.88B
| $485K | ﹤0.01% |
14,548
| – | – |
2020 Q2
10 quarters
|
|
|
MARK
4110
DELISTED
Remark Holdings, Inc.
MARK
| $483K | ﹤0.01% |
438,748
+108,515
| +33% | +$265K |
2013 Q2
38 quarters
|
|
|
BTTX
4111
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
| $480K | ﹤0.01% |
434,779
+135
| +0% | +$199 |
2021 Q4
4 quarters
|
|
4112
Air Industries Group
AIRI
$12.1M
| $476K | ﹤0.01% |
111,985
-4,162
| -4% | -$22.4K |
2017 Q3
21 quarters
|
|
4113
DELISTED
Vaccinex, Inc. Common Stock
VCNX
| $472K | ﹤0.01% |
3,490
+3
| +0.1% | +$372 |
2018 Q3
17 quarters
|
|
4114
Marker Therapeutics
MRKR
$18.5M
| $470K | ﹤0.01% |
176,785
+156
| +0.1% | +$538 |
2017 Q3
21 quarters
|
|
4115
M-tron Industries
MPTI
$290M
| $467K | ﹤0.01% |
+53,367
| New | +$548K |
2022 Q4
0 quarters
|
|
4116
Comstock
LODE
$141M
| $463K | ﹤0.01% |
168,418
-1,893
| -1% | -$6.89K |
2013 Q2
38 quarters
|
|
4117
DELISTED
CASI Pharmaceuticals
CASI
| $461K | ﹤0.01% |
257,618
+175
| +0.1% | +$347 |
2013 Q2
38 quarters
|
|
4118
DELISTED
Trevena, Inc.
TRVN
| $461K | ﹤0.01% |
12,890
+6
| +0% | +$499 |
2014 Q1
35 quarters
|
|
4119
GeoVax Labs
GOVX
$2.15M
| $461K | ﹤0.01% |
1,949
+482
| +33% | +$146K |
2020 Q4
8 quarters
|
|
|
BLU
4120
DELISTED
BELLUS Health Inc.
BLU
| $460K | ﹤0.01% |
55,975
+7,915
| +16% | +$73.8K |
2022 Q2
2 quarters
|
|
|
IMBI
4121
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $459K | ﹤0.01% |
717,145
-11,517
| -2% | -$6.27K |
2014 Q4
32 quarters
|
|
4122
DELISTED
iSun, Inc. Common Stock
ISUN
| $455K | ﹤0.01% |
339,799
+131
| +0% | +$242 |
2020 Q3
9 quarters
|
|
4123
Corbus Pharmaceuticals
CRBP
$86.8M
| $447K | ﹤0.01% |
134,970
+78
| +0.1% | +$300 |
2015 Q2
30 quarters
|
|
4124
DELISTED
CureVac
CVAC
| $447K | ﹤0.01% |
74,083
+1,300
| +2% | +$9.6K |
2021 Q1
7 quarters
|
|
4125
Lisata Therapeutics
LSTA
$11M
| $446K | ﹤0.01% |
176,139
-166
| -0.1% | -$609 |
2013 Q2
38 quarters
|
|
Similar funds
Vanguard Group's Q4 2022 Portfolio in Review
As of Q4 2022, Vanguard Group held 4,644 positions worth $3.67T, up 8% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 3.3%. Vanguard Group opened 41 new positions and exited 112, leaving the 4,644-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Vanguard Group's largest Q4 2022 buy was U-Haul Holding Co Series N: 8,844,620 shares worth $486M.
- Vanguard Group added most to Prologis in Q4 2022, an estimated $2.67B increase.
- Vanguard Group's biggest Q4 2022 reduction was McKesson, cutting an estimated $868M.
- Vanguard Group fully exited Twitter, Inc. in Q4 2022, selling an estimated $3.16B.
- Vanguard Group's ten largest holdings make up 18% of its $3.67T portfolio in Q4 2022.
- Vanguard Group opened 41 new positions and closed 112 in Q4 2022.
- Vanguard Group's portfolio value rose 8% quarter-over-quarter to $3.67T.
Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.